ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05140	Leishmaniasis	2/4	75/7206	0.000632747630735
ko04145	Phagosome	2/4	162/7206	0.00292562381539
ko05164	Influenza A	2/4	167/7206	0.00310666828091
ko05168	Herpes simplex infection	2/4	182/7206	0.00368126841669
ko05167	Kaposi's sarcoma-associated herpesvirus infection	2/4	191/7206	0.00404855542538
ko05169	Epstein-Barr virus infection	2/4	206/7206	0.0046979565878
ko05203	Viral carcinogenesis	2/4	277/7206	0.00839183641541
ko05310	Asthma	1/4	17/7206	0.00940519079942
ko05332	Graft-versus-host disease	1/4	18/7206	0.00995636331817
ko05330	Allograft rejection	1/4	24/7206	0.0132585698593
ko05320	Autoimmune thyroid disease	1/4	29/7206	0.0160040925539
ko04940	Type I diabetes mellitus	1/4	32/7206	0.01764865364
ko05150	Staphylococcus aureus infection	1/4	36/7206	0.0198381940477
ko04672	Intestinal immune network for IgA production	1/4	37/7206	0.0203850067706
ko05416	Viral myocarditis	1/4	55/7206	0.0301885687381
ko05321	Inflammatory bowel disease (IBD)	1/4	56/7206	0.0307310447171
ko04640	Hematopoietic cell lineage	1/4	64/7206	0.0350626638535
ko04612	Antigen processing and presentation	1/4	77/7206	0.0420705598294
ko04664	Fc epsilon RI signaling pathway	1/4	77/7206	0.0420705598294
ko04730	Long-term depression	1/4	78/7206	0.0426080430335
ko04662	B cell receptor signaling pathway	1/4	88/7206	0.0479704438032
ko05323	Rheumatoid arthritis	1/4	89/7206	0.0485054421488